Eligible patients were chronic NSAID and/or acetaminophen ( APAP ) users with baseline Western Ontario and McMasters Universities Osteoarthritis Index ( WOMAC ) pain subscale scores @mm by visual analog scale and an OA flare ( @mm increase in WOMAC pain subscale score following discontinuation of NSAIDs/APAP at screening ) .